OGX-011
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for OGX-011, covering 2012-01-10 to 2023-08-04. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Phase 2]